• 제목/요약/키워드: MIBG

검색결과 35건 처리시간 0.024초

악성 갈색세포종 및 갑상선수질암의 $^{131}I-MIBG$을 이용한 치료 ($^{131}I-MIBG$ Therapy in Malignant Pheochromocytoma and Medullary Thyroid Carcinoma)

  • 윤종길;류백렬;이창희;정상훈;천영국;최창운;임상무;홍성운
    • 대한핵의학회지
    • /
    • 제29권3호
    • /
    • pp.319-327
    • /
    • 1995
  • 목적 : 악성 갈색세포종 및 갑상선수질암의 치료에서 $^{131}I-MIBG$의 유용성에 대하여 분석하고자 한다. 방법 : 1993년 2월부터 1995년 2월까지 원자력병원에서 $^{131}I-MIBG$를 이용하여 치료한 악성 갈색세포종 3예, 갑상선수질암 6예(1예은 다발성 내분비선종 제IIb 형)에 대한 의무기록을 후향적으로 분석하였다. 결과 : 악성 갈색세포종 3예중 수술후 미소전이 병소에 대해 치료한 1예는 19개월간 무병기간을 유지하고 있으며, 수술후 재발한 1예는 불변, 절제가 불가능한 1예는 진행하였다. 갑상선수질암 6예중 평가 가능한 경우는 5예였으며, 완전관해가 2예, 그 중 1예는 완전관해후 9개월에 재발, 불변이지만 증상의 호전이 1예, 진행이 2예였다. 진행되는 환자의 특징은 진단시에 절제불능이거나 수술후 종양이 남아있는 경우로 보였다. 결론 : $^{131}I-MIBG$ 치료는 수술후 미소전이 병소의 치료와 수술후 재발 혹은 전이성 갈색세포종 및 갑상선수질암에서 일부 효과가 있어 다른 선택 가능한 치료방법이 없을 경우 시도해 볼만한 치료방법으로서 향후 충분한 임상례를 통하여 연구되어야 할 것으로 생각된다.

  • PDF

Effects of Motor Imagery Training and Balance Training on Static Balance: A Quasi-Experimental Study

  • Gim, Mina;Choi, Junghyun;Ga, Heayoung
    • 국제물리치료학회지
    • /
    • 제11권1호
    • /
    • pp.1999-2004
    • /
    • 2020
  • Background: Although studies on physical motor learning through motor imagery training have been conducted in various fields, studies on its effectiveness are still considered insufficient. Objective: To investigate the effect of motor imagery training and balance training on static balance of asymptomatic adults in their 20s. Design: A quasi-experimental study. Methods: Thirty-six adults in their 20s who passed the tandem stance test were randomized to the motor imagery training group (MIG, n=12), motor imagery with balance training group (MIBG, n=12), and balance training group (BG, n=12). Each group underwent their respective interventions three times a week for four weeks, and changes in static balance were analyzed using multivariate analysis of variance. Results: Trace length was significantly lower in the MIBG than in the MIG and BG (P<.05), and a significant reduction in trace length in the MIBG was observed after the intervention as compared to the baseline (P<.05). Furthermore, a significantly lower velocity was observed in the MIBG than in the MIG and BG (P<.05), and a significant reduction of velocity in the MIBG was more observed after the intervention compared to the baseline (P<.05). Conclusion: These results suggest that motor imagery training enhance static balance in healthy college students.

갈색세포종이 의심되는 환자의 평가에 있어서 $^{131}I-MIBG$ Scan의 역할 ($^{131}I-MIBG$ Scintigraphy in the Evaluation of Suspected Pheochromocytoma)

  • 오세정;유형식;박창윤;이소진
    • 대한핵의학회지
    • /
    • 제26권2호
    • /
    • pp.365-370
    • /
    • 1992
  • Pheochromocytomas are catecholamine producing tumors of neuroectoderrnal origin. Diagnosis of pheochromocytoma is significant due to potentially curable hypertension. But they have a significant associated morbidity due to uncontrolled hypertension and mortality since 10% are malignant. From Aug. 1989 to Jul. 1992, 12 patients of our institution had $^{131}I-MIBG$ scan during work up of suspected primary or recurrent pheochromocytoma. In our studies conclude that $^{131}I-MIBG$ scan is recommended as the initial localizing study of choice (especially for the detection of extraadrenal disease and postoperative recurrence) as a guide for CT and/or MR and specific functional confirmation of their findings.

  • PDF

$^{131}I$-MIBG Scintigraphy로 진단된 재발성 갈색 세포종 1예 - Report of A Case - (A Case of Recurrent Pheochromocytoma Diagnosed by $^{131}I$-MIBG Scintigraphy)

  • 정동성;이귀래;한창완;조영삼;박운식;정윤형;주홍돈;박성기;김성환;김정례;문대혁
    • 대한핵의학회지
    • /
    • 제28권3호
    • /
    • pp.402-406
    • /
    • 1994
  • 저자등은 10년 전 좌측 부신의 갈색 세포종으로 수술한 후 건강하게 지내다가, 6개월 전부터 증상을 호소하는 49세 남자 환자에서 생화학적 검사상 재발을 확신할 수 없었으나, MIBG scintigraphy로 진단하여 수술을 시행한 부신외 갈색 세포종 1예를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.

  • PDF

이중병소를 가진 갈색종의 $^{131}I-MIBG$ 신티그라피 ($^{131}I-MIBG$ Scintigraphy in Double Focuses Pheochromocytoma)

  • 김학희;정수교;김성훈;박영하;박용휘;신경섭
    • 대한핵의학회지
    • /
    • 제26권1호
    • /
    • pp.151-154
    • /
    • 1992
  • 갈색종은 비교적 드문 종양으로 다발성으로 생기는 경우는 더욱 드물다. 갈색종은 수술로 90%이상 완치 가능한 질환이므로 수술전 종양의 위치와 범위를 정확히 확인하는 것 이 매우 중요하다. 저자들은 최근 파동하는 고혈압을 주소로 내원한 33세 남자환자에서 복부전산화 단층촬영술상 우측부신의 종양만을 확인할 수 있었으나, $^{131}I-MIBG$ 신티그라피에서는 우측 부신의 병소외에 골반강 내에 또다른 병소가 발견되어 골반강 전산화 단층촬영술을 추가로 시행하였고 이어 수술로써 확진된 이중병소의 갈색종 1예를 보고하는 바이다.

  • PDF

양측성 갈색세포종의 초음파, CT, MRI와 $^{131}I-MIBG$ Scan 소견 (A Case of Bilateral Pheochromocytoma: Findings of US, CT, MRI and $^{131}I-MIBG$ Scan)

  • 양승오;최상희;남경진;이영일;김영대;김종성
    • 대한핵의학회지
    • /
    • 제24권2호
    • /
    • pp.332-336
    • /
    • 1990
  • Pheochromocytoma occurs at all ages but is most common in young to midadult life. In adults 10 percent of pheochronocytoma are bilateral. And bilateral lesions are common in the familial syndromes; within Multiple Endocrine Neoplasia (MEN) kindreds over half with pheochromocytomas have bilateral lesions. We report a case of bilateral pheochromocytoma firstly detected by ultrasonogram. This 24-year-old male was normotensive and had symptoms of dilated cardiomyopathy and elevated VMA level. CT and MRI were performed to evaluate the tissue nature and associated abnormalities. $^{131}I-MIBG$ scan seems to be the imaging of choice in patients with suspected multicentric/bilateral or recurrent or metastatic pheochromocytomas.

  • PDF

신경내분비종양의 방사성핵종 치료 (Review of Radionuclide Treatment for Neuroendocrine Tumors)

  • 정환정
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제40권2호
    • /
    • pp.90-95
    • /
    • 2006
  • Neuroendocrine tumors (NETs) consist of a heterogeneous group of tumors that are able to uptake neuroamine and/or specific receptors, such as somatostatin receptors, which can play important roles of the localization and treatment of these tumors. When considering therapy with radionuclides, the best radioligand should be carefully investigated. $^{131}I$-MIBG and beta-particle emitter labeled somatostatin analogs are well established radionuclide therapy modalities for NETs. $^{111}In,\;^{90}Y\;and\;^{177}Lu$ radiolabeled somatostatin analogues have been used for treatment of NETs. Further, radionuclide therapy modalities, for example, radioimmunotherapy, radiolabeled peptides such as minigastrin are currently under development and in different phases of clinical investigation. for all radionuclides used for therapy, long-term and survival statistics are not yet available and only partial tumour responses have been obtained using $^{131}I$-MIBG and $^{111}In$-octreotide. Experimental results using $^{90}Y$-DOTA-lanreotide as well as $^{90}Y-DOTA-D-Phe1-Tyr^3-octreotide$ and/or $^{177}Lu-DOTA-Tyr^3-octreotate$ have indicated the possible clinical potential of radionuclides receptor-targeted radiotherapy it may be hoped that the efficacy of radionuclide therapy will be improved by co-administration of chemotherapeutic drugs whose antitumoral properties may be synergistic with that of irradiation.